Home › Researcher directory › Pascal Laforêt

Pascal Laforêt

Affiliation : Inserm · Université de Versailles Saint-Quentin-en-Yvelines · Université Paris-Saclay · Assistance Publique – Hôpitaux de Paris · Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologie appliquées · Hôpital Raymond-Poincaré

• 7Publications (affiliation in France)
• 711Total publications
• 17738Citations
• 72h-index

ORCIDOpenAlex

Research profile

Pascal Laforêt has 7 indexed publications (2011–2026). Their work appears mainly in “Annals of Clinical and Translational Neurology”, “medRxiv” and “Proceedings of the National Academy of Sciences”. Their most cited article, “A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C” (2011), has been cited 91 times. 4 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United States, Italy.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Glycogen Storage Diseases and Myoclonus
• Metabolism and Genetic Disorders
• Lysosomal Storage Disorders Research
• Muscle Physiology and Disorders
• Neurogenetic and Muscular Disorders Research

Publications (7)

• Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
  2026 · Annals of Clinical and Translational Neurology
• High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
  2026 · medRxiv
• High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
  2026 · Proceedings of the National Academy of Sciences
• Diaphragmatic MRI and 3D spirometry: Potential biomarkers in neuromuscular disorders
  2025 · Clinical Radiology · cited 1 times
• P210 Glycogénose de type III : à propos de deux cas familiaux
  2014 · Diabetes & Metabolism
• Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency
  2012 · Journal of the Neurological Sciences · cited 24 times
• A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C
  2011 · Brain · cited 91 times

Publication venues

• Annals of Clinical and Translational Neurology × 1
• medRxiv × 1
• Proceedings of the National Academy of Sciences × 1
• Clinical Radiology × 1
• Diabetes & Metabolism × 1
• Journal of the Neurological Sciences × 1

Publications per year

• 20263
• 20251
• 20141
• 20121
• 20111

Collaborations

Partner institutions : Hôpital Necker-Enfants Malades · Institut des Maladies Génétiques Imagine · Pitié-Salpêtrière Hospital · Institut de Myologie · ERN EURO-NMD

Co-authors’ countries : United States · Italy

Co-authors

• Emilie Rocher
• Marie‐Céline Fleury
• Rocío N. Villar‐Quiles
• Laurent Abel
• Nicolas Girard
• Karolina Hankiewicz
• Shahram Attarian
• Thierry Jo Molina
• Cyril Gitiaux
• Florent Wallet
• Vivien Béziat
• Kahina Saker

Bibliographic data from OpenAlex (open database).